Literature DB >> 18431323

Diagnosis and management of primary progressive multiple sclerosis.

T M Jenkins1, Z Khaleeli, A J Thompson.   

Abstract

Primary progressive multiple sclerosis (MS) is a chronic demyelinating degenerative disorder of the central nervous system. The most common presentation is with a spastic paraparesis, which may be asymmetrical. In contrast to relapsing remitting MS, discrete attacks are not a characteristic feature and the temporal course is of gradual symptomatic deterioration. The current diagnostic criteria are based on this clinical phenotype, with supportive evidence from magnetic resonance imaging, and examination of cerebrospinal fluid and visual evoked potentials in some cases. At present, there is no effective disease modifying therapy, but a wide range of symptomatic treatments are available. These may be of great benefit to individual patients and include pharmacological measures, multidisciplinary therapist input and neurorehabilitation. New treatments which target neurodegeneration and promote brain repair are required, and research in these areas offers hope for the future.

Entities:  

Mesh:

Year:  2008        PMID: 18431323

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  2 in total

1.  A case of anti-myelin-associated glycoprotein polyneuropathy and multiple sclerosis: one disease instead of two?

Authors:  Stefano Sotgiu; Alessandra Giua; Maria R Murrighile; Renato Ortu
Journal:  BMJ Case Rep       Date:  2009-02-20

2.  Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis.

Authors:  Xiaoming Jia; Lohith Madireddy; Stacy Caillier; Adam Santaniello; Federica Esposito; Giancarlo Comi; Olaf Stuve; Yuan Zhou; Bruce Taylor; Trevor Kilpatrick; Filippo Martinelli-Boneschi; Bruce A C Cree; Jorge R Oksenberg; Stephen L Hauser; Sergio E Baranzini
Journal:  Ann Neurol       Date:  2018-07-03       Impact factor: 10.422

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.